Stock Scorer

Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems, Inc. reported revenue of 200.6M USD for the quarter ending 30 June 2026, down 7.6% from 217.1M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 200.6M -7.6%
Gross Profit Q2 '26 · ending 30 June 2026 171.5M -6.0%
Operating Income Q2 '26 · ending 30 June 2026 -514K —
Net Income Q2 '26 · ending 30 June 2026 314K —
Cost of Revenue Q2 '26 · ending 30 June 2026 29.1M -16.0%
Operating Cash Flow Q2 '26 · ending 30 June 2026 23.2M +765.4%
Free Cash Flow Q2 '26 · ending 30 June 2026 14.1M —
Shares Outstanding Q2 '26 · ending 30 June 2026 28.9M -4.5%
EPS Q2 '26 · ending 30 June 2026 4.54 +162.4%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 912M51M145.4M78.5M
20242024-12-31 802.8M36.1M53.5M91.1M
20232023-12-31 624.8M-40.3M-21.2M1M
20222022-12-31 407.9M-47.6M-44.9M2.5M
20212021-12-31 233.4M-39.9M-42M-24.8M
20202020-12-31 115.4M-56.2M-57.2M-55.5M
20192019-12-31 82M-34.9M-33.2M-35.6M
20182018-12-31 50.6M-20.4M-21.8M-18.9M
20172017-12-31 28.6M-16M-17.5M-16.2M
20162016-12-31 16.4M-17.3M-18.5M-18.3M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30200.6M
Q1 '262026-03-31204.6M
Q4 '252025-12-31269.1M
Q3 '252025-09-30224.5M
Q2 '252025-06-30217.1M
Q1 '252025-03-31201.3M
Q4 '242024-12-31239.7M
Q3 '242024-09-30203.2M
Q2 '242024-06-30195.9M
Q1 '242024-03-31164M
Q4 '232023-12-31192.5M
Q3 '232023-09-30153.3M
Q2 '232023-06-30151.1M
Q1 '232023-03-31127.9M
Q4 '222022-12-31137.9M
Q3 '222022-09-30109.2M
Q2 '222022-06-3091.4M
Q1 '222022-03-3169.4M
Q4 '212021-12-3178.4M
Q3 '212021-09-3061.7M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30171.5M
Q1 '262026-03-31176.9M
Q4 '252025-12-31233M
Q3 '252025-09-30192.7M
Q2 '252025-06-30182.4M
Q1 '252025-03-31170.6M
Q4 '242024-12-31203.7M
Q3 '242024-09-30170.8M
Q2 '242024-06-30166M
Q1 '242024-03-31139.3M
Q4 '232023-12-31164.5M
Q3 '232023-09-30128.9M
Q2 '232023-06-30126.8M
Q1 '232023-03-31108M
Q4 '222022-12-31115.7M
Q3 '222022-09-3089.4M
Q2 '222022-06-3077.2M
Q1 '222022-03-3159.4M
Q4 '212021-12-3167.2M
Q3 '212021-09-3053.1M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-514K
Q1 '262026-03-31-1.1M
Q4 '252025-12-3146.1M
Q3 '252025-09-309.6M
Q2 '252025-06-30-3.3M
Q1 '252025-03-31-1.5M
Q4 '242024-12-3131.9M
Q3 '242024-09-3014.3M
Q2 '242024-06-305.1M
Q1 '242024-03-31-15.2M
Q4 '232023-12-319.3M
Q3 '232023-09-30-13.5M
Q2 '232023-06-30-16.6M
Q1 '232023-03-31-19.5M
Q4 '222022-12-31-335K
Q3 '222022-09-30-17.2M
Q2 '222022-06-30-14M
Q1 '222022-03-31-16.1M
Q4 '212021-12-31-1.8M
Q3 '212021-09-30-9.8M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30314K
Q1 '262026-03-31-11.3M
Q4 '252025-12-31136.1M
Q3 '252025-09-309.9M
Q2 '252025-06-30-3.6M
Q1 '252025-03-313M
Q4 '242024-12-3135.2M
Q3 '242024-09-3018.5M
Q2 '242024-06-309.8M
Q1 '242024-03-31-10M
Q4 '232023-12-3114.8M
Q3 '232023-09-30-8.5M
Q2 '232023-06-30-12M
Q1 '232023-03-31-15.4M
Q4 '222022-12-313.1M
Q3 '222022-09-30-16.8M
Q2 '222022-06-30-14.5M
Q1 '222022-03-31-16.7M
Q4 '212021-12-31-2.4M
Q3 '212021-09-30-10.3M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3029.1M
Q1 '262026-03-3127.7M
Q4 '252025-12-3136.1M
Q3 '252025-09-3031.8M
Q2 '252025-06-3034.7M
Q1 '252025-03-3130.7M
Q4 '242024-12-3136M
Q3 '242024-09-3032.4M
Q2 '242024-06-3029.8M
Q1 '242024-03-3124.8M
Q4 '232023-12-3128.1M
Q3 '232023-09-3024.4M
Q2 '232023-06-3024.3M
Q1 '232023-03-3119.9M
Q4 '222022-12-3122.2M
Q3 '222022-09-3019.8M
Q2 '222022-06-3014.2M
Q1 '222022-03-3110M
Q4 '212021-12-3111.2M
Q3 '212021-09-308.6M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3023.2M
Q1 '262026-03-3112.8M
Q4 '252025-12-3152.5M
Q3 '252025-09-3068.5M
Q2 '252025-06-302.7M
Q1 '252025-03-31-6.7M
Q4 '242024-12-3169.2M
Q3 '242024-09-3052.3M
Q2 '242024-06-30-78K
Q1 '242024-03-318.9M
Q4 '232023-12-3117.3M
Q3 '232023-09-303.6M
Q2 '232023-06-305.1M
Q1 '232023-03-31-1.3M
Q4 '222022-12-3119.3M
Q3 '222022-09-3011M
Q2 '222022-06-30-6M
Q1 '222022-03-31-12.7M
Q4 '212021-12-31734K
Q3 '212021-09-30-338K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3014.1M
Q1 '262026-03-313.1M
Q4 '252025-12-3141.8M
Q3 '252025-09-3058.1M
Q2 '252025-06-30-6.3M
Q1 '252025-03-31-15.1M
Q4 '242024-12-3162.2M
Q3 '242024-09-3044.3M
Q2 '242024-06-30-12.5M
Q1 '242024-03-31-2.8M
Q4 '232023-12-319.2M
Q3 '232023-09-30-3.4M
Q2 '232023-06-30237K
Q1 '232023-03-31-5.1M
Q4 '222022-12-3116.3M
Q3 '222022-09-307.5M
Q2 '222022-06-30-7.4M
Q1 '222022-03-31-14M
Q4 '212021-12-31201K
Q3 '212021-09-30-1.5M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3028.9M
Q1 '262026-03-3128.7M
Q3 '252025-09-3029.6M
Q2 '252025-06-3029.5M
Q1 '252025-03-3130.3M
Q3 '242024-09-3030.6M
Q2 '242024-06-3030.4M
Q1 '242024-03-3129.6M
Q3 '232023-09-3029.4M
Q2 '232023-06-3029.2M
Q1 '232023-03-3129.1M
Q3 '222022-09-3028.2M
Q2 '222022-06-3027.6M
Q1 '222022-03-3127.5M
Q3 '212021-09-3027.3M
Q2 '212021-06-3027.2M
Q1 '212021-03-3127.1M
Q3 '202020-09-3026.8M
Q2 '202020-06-3026.3M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-304.54
Q1 '262026-03-314.41
Q4 '252025-12-314.90
Q3 '252025-09-301.47
Q2 '252025-06-301.73
Q1 '252025-03-312.17
Q4 '242024-12-311.73
Q3 '242024-09-301.09
Q2 '242024-06-300.20
Q1 '242024-03-31-0.53
Q4 '232023-12-31-0.72
Q3 '232023-09-30-1.09
Q2 '232023-06-30-1.40
Q1 '232023-03-31-1.52
Q4 '222022-12-31-1.60
Q3 '222022-09-30-1.82
Q2 '222022-06-30-1.60
Q1 '222022-03-31-1.55
Q4 '212021-12-31-1.54
Q3 '212021-09-30-1.72